NVN Liquidation Inc (NOVNQ)
0.0008
0.00 (0.00%)
USD |
OTCM |
Apr 26, 16:00
NVN Liquidation Total Liabilities (Quarterly): 82.62M for March 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2023 | 82.62M |
| December 31, 2022 | 85.72M |
| September 30, 2022 | 76.51M |
| June 30, 2022 | 102.14M |
| March 31, 2022 | 106.17M |
| December 31, 2021 | 50.64M |
| September 30, 2021 | 47.70M |
| June 30, 2021 | 47.39M |
| March 31, 2021 | 46.13M |
| December 31, 2020 | 43.85M |
| September 30, 2020 | 39.12M |
| June 30, 2020 | 46.89M |
| March 31, 2020 | 48.87M |
| December 31, 2019 | 51.38M |
| September 30, 2019 | 64.32M |
| Date | Value |
|---|---|
| June 30, 2019 | 67.72M |
| March 31, 2019 | 24.16M |
| December 31, 2018 | 19.92M |
| September 30, 2018 | 31.99M |
| June 30, 2018 | 34.36M |
| March 31, 2018 | 34.92M |
| December 31, 2017 | 22.85M |
| September 30, 2017 | 23.90M |
| June 30, 2017 | 25.72M |
| March 31, 2017 | 27.84M |
| December 31, 2016 | 21.41M |
| September 30, 2016 | 27.02M |
| June 30, 2016 | 16.77M |
| December 31, 2015 | 109.90M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
39.12M
Minimum
Sep 2020
106.17M
Maximum
Mar 2022
62.95M
Average
51.01M
Median
Total Liabilities (Quarterly) Benchmarks
| Cantabio Pharmaceuticals Inc | 2.215M |
| Q BioMed Inc | 9.906M |
| Affymax Inc | -- |
| Scopus BioPharma Inc | 11.00M |
| Statera BioPharma Inc | 22.92M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 79.79M |
| Shareholders Equity (Quarterly) | -2.828M |